The Centers for Disease Control and Prevention (CDC) and the U.S. Food and Drug Administration (FDA) are reviewing data involving six reported U.S. cases of a rare and severe type of blood clot in individuals after receiving the Johnson & Johnson (Janssen) COVID-19 vaccine. On Thursday morning, April 13th, 2021, the FDA recommended a temporary pause on the administration of Johnson & Johnson COVID-19 vaccination until they have had a chance to review the data and provide guidance for healthcare providers.

Visit https://emergency.cdc.gov/han/2021/pdf/CDC-HAN-00442.pdf for recommendations.